Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 2250 of 46697 entries
View as:
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 8
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 17
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 148
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 994
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 10
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 46
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| American Society of Clinical Oncology | - | 3 | 0.0% | 0 | 0 | 0.0% | - | American Society of Clinical Oncology.temp.org | 2025-07-14 |
| American Society of Hematology | - | 1 | 0.0% | 0 | 0 | 0.0% | - | American Society of Hematology.temp.org | 2025-07-14 |
| American Thrombosis and Hemostasis Network | - | 8 | 0.0% | 0 | 0 | 0.0% | - | American Thrombosis and Hemostasis Network.temp.org | 2025-07-14 |
| American University | - | 17 | 0.0% | 0 | 0 | 0.0% | - | American University.temp.org | 2025-07-14 |
| American University Of Montserrat | - | 1 | 0.0% | 0 | 0 | 0.0% | - | American University Of Montserrat.temp.org | 2025-07-14 |
| American University of Beirut Medical Center | - | 148 | 0.0% | 0 | 0 | 0.0% | - | American University of Beirut Medical Center.temp.org | 2025-07-14 |
| American University of Sharfah | - | 1 | 0.0% | 0 | 0 | 0.0% | - | American University of Sharfah.temp.org | 2025-07-14 |
| American Venous Forum | - | 1 | 0.0% | 0 | 0 | 0.0% | - | American Venous Forum.temp.org | 2025-07-14 |
| American-European Congress of Ophthalmic Surgery | - | 1 | 0.0% | 0 | 0 | 0.0% | - | American-European Congress of Ophthalmic Surgery.temp.org | 2025-07-14 |
| Amerigo Giudice | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Amerigo Giudice.temp.org | 2025-07-14 |
| Ameritek USA | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Ameritek USA.temp.org | 2025-07-14 |
| Amersham Buchler, GmbH & Co KG | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Amersham Buchler, GmbH & Co KG.temp.org | 2025-07-14 |
| Amgen | - | 994 | 0.0% | 0 | 0 | 0.0% | - | Amgen.temp.org | 2025-07-14 |
| Amgen Research (Munich) GmbH | - | 10 | 0.0% | 0 | 0 | 0.0% | - | Amgen Research (Munich) GmbH.temp.org | 2025-07-14 |
| Amicus Therapeutics | - | 46 | 0.0% | 0 | 0 | 0.0% | - | Amicus Therapeutics.temp.org | 2025-07-14 |
| Amicus Therapeutics France SAS | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Amicus Therapeutics France SAS.temp.org | 2025-07-14 |
| Amila Haskic | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Amila Haskic.temp.org | 2025-07-14 |
| Amin El Sayed Nawar | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Amin El Sayed Nawar.temp.org | 2025-07-14 |
| Amin Javer | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Amin Javer.temp.org | 2025-07-14 |
| Amina Altutunji | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Amina Altutunji.temp.org | 2025-07-14 |
| Amina Aslam | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Amina Aslam.temp.org | 2025-07-14 |
| Amina Fouad Farag | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Amina Fouad Farag.temp.org | 2025-07-14 |
| Amine Terzi | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Amine Terzi.temp.org | 2025-07-14 |
| Aminex Therapeutics, Inc. | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Aminex Therapeutics, Inc..temp.org | 2025-07-14 |
| Amino Up Chemicals Co., Ltd. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Amino Up Chemicals Co., Ltd..temp.org | 2025-07-14 |